Enterprise talent title evaluation has a "through train" peak six employees become "innovative engineers"
Release time:
2023-06-07
As long as you are willing to innovate and achieve results, you can also evaluate professional titles with low academic qualifications. A few days ago, 6 employees of Jianfeng passed the evaluation of Jinhua Municipal People's Social Security Bureau and became "innovative engineers", including 4 cable companies and 2 health technology companies. The cultivation and evaluation of
enterprise innovation engineers is an important measure for Jinhua City to identify innovative talents, further smooth the channel for talent growth, accelerate the construction of enterprise professional and technical personnel, and promote the high-quality development of the local economy. The key point is to overcome the tendency of academic qualifications, qualifications and awards, deepen the reform of the professional title evaluation system of enterprise professional and technical personnel, and establish a "through train" for the evaluation of professional titles of enterprise talents ".
insists on innovation-driven, high-end leadership, highlights work ability and performance contribution, and takes patent achievements, technical skills, standard development, achievement transformation and so on as the main content, which is the focus and highlight of the "through train" of enterprise innovation engineers. According to the ''Jinhua City Enterprise Innovation Engineer Evaluation Measures (Trial) ''issued by the Jinhua Municipal Bureau of Human Resources and Social Security in 2022, it adheres to the ability, performance and contribution-oriented, and follows the principles of social recognition, industry recognition, special evaluation, simplicity and speed. Personnel engaged in engineering professional and technical work in Jinhua's 2 4 X characteristic industries.
Innovation, results, these two keywords are fully reflected in the application conditions selected by innovative engineers. As stipulated in the evaluation method, participating in the completion of science and technology projects at or above the county level (excluding the hosts and participants of sub-projects), the project has passed the acceptance; more than 1 authorized invention patent or more than 3 utility model patents or more than 3 software copyrights; Participate in the preparation of more than 3 standards at or above the county level, and promulgate and implement; Participants who have won awards for engineering projects, achievements, and technologies at or above the county level; engaged in relevant professional work for at least 3 years, participating in the research and development of new technologies, new products, new processes, new varieties, etc., and making outstanding contributions; in key common technologies, cutting-edge leading technologies, modern engineering technologies, and disruptive technological innovations If you solve a key problem in detail, these six declaration conditions can be declared as long as they meet one of them. Wang Debo, Lu Chaofang, Guo Zhijian and Shen Ke, four innovation engineers of
Peak Cable Company, are the first and second batch of judges who passed the "211" training plan for enterprise innovation engineers in Jinhua. The four have done a lot of work in equipment transformation, new product research and development, product performance improvement and improvement, etc., and have achieved certain results in the transformation of patents, government research and development projects, etc., and have made positive contributions to the company's development and created greater Economic benefits. Lou Yongzeng and Zhao Hujun, two innovative engineers of the Health Technology Company, actively explored the company's product research and development and process innovation, and participated in a number of technical research such as the combination identification method of resveratrol and its dimer from grapevine and cranberry extract. Some of the achievements have obtained invention patents.
With the "through train" of enterprise innovation engineer evaluation, it has opened up the growth channel of professional title evaluation and personal promotion for innovative talents with low academic qualifications and no professional titles in the enterprise. It has more confidence for the majority of grass-roots employees to move into the technical field and provides strong talent support for the development of the real industry. (lu chao-fang)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31